Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study-Reference-Cited by-同舟云学术

Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study

Published:2019-09 Issue:9 Volume:4 Page:711-720
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Lowery Maeve A,Burris Howard A,Janku Filip,Shroff Rachna T,Cleary James M,Azad Nilofer S,Goyal Lipika,Maher Elizabeth A,Gore Lia,Hollebecque Antoine,Beeram Muralidhar,Trent Jonathan C,Jiang Liewen,Fan Bin,Aguado-Fraile Elia,Choe Sung,Wu Bin,Gliser Camelia,Agresta Samuel V,Pandya Shuchi S,Zhu Andrew X,Abou-Alfa Ghassan K

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment;Blechacz;Hepatology,2008

2. Epithelial-to-mesenchymal transition and cancer invasiveness: what can we learn from cholangiocarcinoma?;Brivio;J Clin Med,2015

3. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

4. Chemotherapy for cholangiocarcinoma: an update;Ramírez-Merino;World J Gastrointest Oncol,2013

5. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping;Borger;Oncologist,2012

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma;Oncology in Clinical Practice;2024-08-21

2. Gliomagenesis, Epileptogenesis, and Remodeling of Neural Circuits: Relevance for Novel Treatment Strategies in Low- and High-Grade Gliomas;International Journal of Molecular Sciences;2024-08-16

3. Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies;Biomarkers in Medicine;2024-08-15

4. Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives;Cancers;2024-08-02

5. PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer;npj Precision Oncology;2024-08-01